QRG Capital Management Inc. Sells 9,772 Shares of Encompass Health Corporation $EHC

QRG Capital Management Inc. reduced its position in shares of Encompass Health Corporation (NYSE:EHC) by 54.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,047 shares of the company’s stock after selling 9,772 shares during the quarter. QRG Capital Management Inc.’s holdings in Encompass Health were worth $1,022,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Ethic Inc. bought a new stake in shares of Encompass Health in the 3rd quarter worth approximately $1,272,000. Belpointe Asset Management LLC purchased a new position in Encompass Health during the second quarter valued at $210,000. Marshall Wace LLP bought a new stake in Encompass Health in the second quarter worth $34,719,000. Bahl & Gaynor Inc. grew its stake in shares of Encompass Health by 14.8% in the second quarter. Bahl & Gaynor Inc. now owns 288,226 shares of the company’s stock worth $35,345,000 after acquiring an additional 37,161 shares during the last quarter. Finally, Park Avenue Securities LLC increased its holdings in shares of Encompass Health by 28.5% during the second quarter. Park Avenue Securities LLC now owns 9,153 shares of the company’s stock valued at $1,122,000 after acquiring an additional 2,030 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Down 1.7%

Shares of Encompass Health stock opened at $98.76 on Wednesday. Encompass Health Corporation has a twelve month low of $92.53 and a twelve month high of $127.99. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.76. The company’s 50 day moving average is $108.71 and its 200 day moving average is $115.99. The company has a market cap of $9.94 billion, a price-to-earnings ratio of 18.67, a price-to-earnings-growth ratio of 1.62 and a beta of 0.74.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, October 29th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.04. The business had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.48 billion. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The company’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.03 EPS. Research analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd were given a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Friday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 14.37%.

Wall Street Analyst Weigh In

Several brokerages recently commented on EHC. UBS Group increased their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Thursday, October 2nd. Barclays increased their price target on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Raymond James Financial upgraded Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Finally, Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $142.86.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.